Inhibiting the Type 2 Inflammatory Pathway with Dupilumab is Associated with an Increase in IL ‐4 and IL‐18 Production

Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Tags: RESEARCH NOTE Source Type: research